Paula Morris

Researcher

UAMS

Formerly Arkansas Affiliated with UA Little Rock, UAMS through 2018.

Faculty Researcher

13 h-index 33 pubs 671 cited

Research Areas

Biomedical Subjects

Links

Research Group

OverviewAI-generated summary

Paula Morris's research focuses on the safety and effectiveness of pharmaceutical interventions for juvenile idiopathic arthritis. Her work includes a 2024 publication on the abatacept registry for this condition. Morris has also published on topics related to literary studies, specifically examining Commonwealth writers and identity in contemporary women's writing from Aotearoa New Zealand. Her scholarly output includes 33 publications with a total of 671 citations, and her h-index is 13. She has collaborated with Jackeline Rodriguez‐Smith at the University of Arkansas for Medical Sciences on one shared publication.

Metrics

h-index: 13
Publications: 33
Citations: 671

Selected Publications

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy (2018)

Arthritis & Rheumatology 83 citations DOI OpenAlex
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease (2018)

Arthritis & Rheumatology 39 citations DOI OpenAlex
High Levels of <scp>DEK</scp> Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy (2017)

Arthritis & Rheumatology 18 citations DOI OpenAlex
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry (2014)

Pediatric Rheumatology 33 citations DOI OpenAlex
A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical Outcomes (2014)

Arthritis & Rheumatology 1 citation DOI OpenAlex
A12: The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis (2014)

Arthritis & Rheumatology 1 citation DOI OpenAlex
A68: The Role of Serum S100A12 Protein Levels in Maintaining Inactive Disease on Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis (2014)

Arthritis & Rheumatology 2 citations DOI OpenAlex
Understanding the biology and use of anti-TNF agents in JIA – interim results (2012)

Pediatric Rheumatology DOI OpenAlex
Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update (2010)

Journal of Pediatric Hematology/Oncology 65 citations DOI OpenAlex
Lymphoma Arising From a Calcinotic Lesion in a Patient with Juvenile Dermatomyositis (2009)

Pediatric Dermatology 14 citations DOI OpenAlex
NUTRITIONAL STATUS OF CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS TREATED WITH METHOTREXATE AND SUPPLEMENTED WITH FOLATE. • 2340 (1996)

Pediatric Research DOI OpenAlex